Sutro Biopharma, Inc. (FRA:S09)
Germany flag Germany · Delayed Price · Currency is EUR
0.7625
+0.0210 (2.83%)
Last updated: Dec 1, 2025, 9:59 AM CET

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $9.69M USD in the quarter ending September 30, 2025, with 13.77% growth. This brings the company's revenue in the last twelve months to $105.65M, down -34.36% year-over-year. In the year 2024, Sutro Biopharma had annual revenue of $62.04M, down -59.64%.

Revenue (ttm)
$105.65M
Revenue Growth
-34.36%
P/S Ratio
0.65
Revenue / Employee
$340.79K
Employees
310
Market Cap
58.70M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202462.04M-91.69M-59.64%
Dec 31, 2023153.73M85.96M126.84%
Dec 31, 202267.77M5.89M9.52%
Dec 31, 202161.88M19.16M44.84%
Dec 31, 202042.72M-14.00K-0.03%
Dec 31, 201942.74M4.32M11.24%
Dec 31, 201838.42M-13.32M-25.75%
Dec 31, 201751.74M-67.72M-56.69%
Dec 31, 2016119.46M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition